PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

An HPLC method for the determination of moxifloxacin in breast milk by fluorimetric detection with precolumn derivatization

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
A new, sensitive, and selective high-performance liquid chromatography (HPLC) method with fluorimetric detection was developed for the determination of moxifloxacin (MOX) in human breast milk. MOX was precolumn derivatized with fluorescamine; the fluorescent derivative was separated on an RP C18 column using a mobile phase composed of acetonitrile–10 mM orthophosphoric acid by isocratic elution with flow rate of 0.5 mL min -1. The method was based on the measurement of the derivative using fluorescence detection at 481 nm with excitation at 351 nm. The calibration curve was linear over the range of 1–40 μg Ml -1. Limit of detection (LOD) and limit of quantitation (LOQ) were found to be 0.3 and 1 μg Ml -1, respectively. Intra-day and interday repeatabilities were less than 3.15%.
Rocznik
Strony
57--65
Opis fizyczny
Bibliogr. 20 poz., rys., tab.
Twórcy
  • Bezmialem Vakif University, Faculty of Pharmacy, Department of Analytical Chemistry, 34093 Fatih, Istanbul, Turkey
autor
  • Bezmialem Vakif University, Faculty of Pharmacy, Department of Analytical Chemistry, 34093 Fatih, Istanbul, Turkey
  • Bezmialem Vakif University, Faculty of Pharmacy, Department of Analytical Chemistry, 34093 Fatih, Istanbul, Turkey
Bibliografia
  • [1] L.L. Brunton, B.A. Chabner, and B.C. Knollmann, Goodman and Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill Medical, 2011
  • [2] J.K. Aranson, Moxifloxacin Meyler's Side Effects of Drugs, 16th edn., Elsevier, 2016, pp. 1129–1134
  • [3] T. Lemoine, D. Breilh, D. Ducint, J. Dubrez, J. Jougon, J.F. Velly, and M.C. Saux, J. Chromatogr. B, 742 (2), 247 (2000)
  • [4] A.L. Djurdjevic, M.J. Stankov, and P. Djurdjevic, J. Chromatogr. B, 844 (1), 104 (2006)
  • [5] A.K.H. Kumar and G. Ramachandran, J. Chromatogr. B, 877 (11–12), 1205 (2009)
  • [6] J. Sousa, G. Alves, G. Campos, A. Fortuna, and A. Falcão, J. Chromatogr. B, 930 (1), 104 (2013)
  • [7] Y.H. Xu, D. Li, X.Y. Liu, Y.Z. Li, and J. Lu, J. Chromatogr. B, 878 (32), 3437 (2010)
  • [8] K.P. Chan, K.O. Chu, W.W. Kwan Lai, K.W. Choy, C.C. Wang, D.S. Chiu Lam, and C.P. Pang, Anal. Biochem., 353 (1), 30 (2006)
  • [9] H.A. Nguyen, J. Grellet, B.B. Ba, C. Quentin, and M.C. Saux, J. Chromatogr. B, 810 (1), 77, 2004
  • [10] K. Vishwanathan, M.G. Bartlett, and J.T. Stewart, J. Pharm. and Biomed. Anal., 30 (4), 961 (2002)
  • [11] H. Liang, M.B. Kays, and K.M. Sowinski, J. Chromatogr. B, 772 (1), 53 (2002)
  • [12] M.A.G. Trindade, G.M. Silva, and V.S. Ferreira, Microchem J,. 81 (2), 209 (2005)
  • [13] J.G. Möller, H. Staß, R. Heinig, and G. Blaschke, J. Chromatogr. B, 716 (1–2), 325 (1998)
  • [14] S. Padberg, Anti-infectives, Drugs During Pregnancy and Lactation, 3rd edn., 2015, pp. 687–703
  • [15] S. Stein, P. Bohlen, J. Stone, W. Dairman, and Undenfriend, S. Arch. Biochem. Biophys. 155 (1), 203 (1973)
  • [16] M. Douša, P. Gibala, and K. Lemr, J. Pharm. Biomed. Anal., 53 (3), 717 (2010)
  • [17] X. Huang, X.F. Guo, H. Wang, and H.S. Zhang, Arabian J. Chem., In Press, Corrected Proof, available online December 2014
  • [18] X. Huang and M. Hernick, Anal. Biochem. 414 (2), 278 (2011)
  • [19] P. Job, Anal. Chem. 9, 113 (1928)
  • [20] Text on validation of analytical procedures Q2A, Technical requirements for registration of pharmaceuticals for human use. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, 2005
Uwagi
PL
Opracowanie ze środków MNiSW w ramach umowy 812/P-DUN/2016 na działalność upowszechniającą naukę (zadania 2017).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-74f53322-947d-4aeb-bc8a-38d5f8a3e98d
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.